Open access · CC-BY
via OpenAlex
Age-related macular degeneration
Community Eye Health Journal · 2014 · ▲ 19 citations
Abstract
What is AMD?Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older.It affects about 8.7% of the world's population and is the leading cause of blindness among people aged 50 and older in industrialised countries.1 AMD affects the macula.When it becomes advanced, it destroys the central vision we use to look straight ahead.This is necessary for recognising faces, reading books or using mobile phone screens, watching television, sewing, preparing food, driving, safely navigating stairs and performing other daily tasks we take for granted.If the macula is damaged, the picture is there but the fine points are not clear.Fortunately, the peripheral vision remains intact.This means that some patients with AMD will retain some independence, and eye workers should reassure them that peripheral vision will not be lost, even if no treatment is possible.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.56920/cehj.730
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Mathenge, W.C. (2014). Age-related macular degeneration. <em>Community Eye Health Journal</em>. https://doi.org/10.56920/cehj.730
Vancouver
Mathenge WC. Age-related macular degeneration. Community Eye Health Journal. 2014. doi:10.56920/cehj.730.
BibTeX
@article{wanjiku2014Agerel,
title = {Age-related macular degeneration},
author = {Wanjiku Ciku Mathenge},
journal = {Community Eye Health Journal},
year = {2014},
doi = {10.56920/cehj.730},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell and Tissue Research 2021
Open access · CC-BY
Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives
EBM Guidelines 2000
Citation only
Age-related macular degeneration (AMD)
Health and Quality of Life Outcomes 2006
Open access · CC-BY
Quality of life in age-related macular degeneration: a review of the literature
Tan Tock Seng Hospital 2025
Open access · US-GOV
AVIGA3: Using an 'Automated Vision Assessment and Impairment Detection Through Gaze Analysis' Through a Longitudinal, Open-labelled, Randomized Clinical Trial to Monitor Recurrence of Aged-related Macular Degeneration in a Home-based Setting (Cohort 2.0).
Zhonghua shiyan yanke zazhi 2019
Citation only
The research status and the limitations of mesenchymal stem cell-based therapies in age-related macular degeneration
New England Journal of Medicine 2008
Citation only